BIOMAT Database Logo BIOMAT Database Logo

Interference of rivaroxaban in one-stage and chromogenic factor VIII:C assays. 2011

V Tichelaar, and H de Jong, and H Nijland, and H Kluin-Nelemans, and K Meijer, and A Mulder

UI MeSH Term Description Entries
D009025 Morpholines Tetrahydro-1,4-Oxazines,Tetrahydro 1,4 Oxazines
D009426 Netherlands Country located in EUROPE. It is bordered by the NORTH SEA, BELGIUM, and GERMANY. Constituent areas are Aruba, Curacao, and Sint Maarten, formerly included in the NETHERLANDS ANTILLES. Holland,Kingdom of the Netherlands
D010314 Partial Thromboplastin Time The time required for the appearance of FIBRIN strands following the mixing of PLASMA with phospholipid platelet substitute (e.g., crude cephalins, soybean phosphatides). It is a test of the intrinsic pathway (factors VIII, IX, XI, and XII) and the common pathway (fibrinogen, prothrombin, factors V and X) of BLOOD COAGULATION. It is used as a screening test and to monitor HEPARIN therapy. Activated Partial Thromboplastin Time,Cephalin-Kaolin Coagulation Time,Kaolin-Cephalin Coagulation Time,Thromboplastin Time, Partial,Coagulation Time, Cephalin-Kaolin,Cephalin Kaolin Coagulation Time,Coagulation Time, Cephalin Kaolin,Coagulation Time, Kaolin-Cephalin,Kaolin Cephalin Coagulation Time
D011237 Predictive Value of Tests In screening and diagnostic tests, the probability that a person with a positive test is a true positive (i.e., has the disease), is referred to as the predictive value of a positive test; whereas, the predictive value of a negative test is the probability that the person with a negative test does not have the disease. Predictive value is related to the sensitivity and specificity of the test. Negative Predictive Value,Positive Predictive Value,Predictive Value Of Test,Predictive Values Of Tests,Negative Predictive Values,Positive Predictive Values,Predictive Value, Negative,Predictive Value, Positive
D011517 Prothrombin Time Clotting time of PLASMA recalcified in the presence of excess TISSUE THROMBOPLASTIN. Factors measured are FIBRINOGEN; PROTHROMBIN; FACTOR V; FACTOR VII; and FACTOR X. It is used for monitoring anticoagulant therapy with COUMARINS. Quick Test,Russell's Viper Venom Time,Thrombotest,Russell Viper Venom Time,Russells Viper Venom Time,Prothrombin Times,Test, Quick,Time, Prothrombin,Times, Prothrombin
D001777 Blood Coagulation The process of the interaction of BLOOD COAGULATION FACTORS that results in an insoluble FIBRIN clot. Blood Clotting,Coagulation, Blood,Blood Clottings,Clotting, Blood
D001780 Blood Coagulation Tests Laboratory tests for evaluating the individual's clotting mechanism. Coagulation Tests, Blood,Tests, Blood Coagulation,Blood Coagulation Test,Coagulation Test, Blood,Test, Blood Coagulation
D004305 Dose-Response Relationship, Drug The relationship between the dose of an administered drug and the response of the organism to the drug. Dose Response Relationship, Drug,Dose-Response Relationships, Drug,Drug Dose-Response Relationship,Drug Dose-Response Relationships,Relationship, Drug Dose-Response,Relationships, Drug Dose-Response
D005169 Factor VIII Factor VIII of blood coagulation. Antihemophilic factor that is part of the factor VIII/von Willebrand factor complex. Factor VIII is produced in the liver and acts in the intrinsic pathway of blood coagulation. It serves as a cofactor in factor X activation and this action is markedly enhanced by small amounts of thrombin. Coagulation Factor VIII,Factor VIII Clotting Antigen,Factor VIII Coagulant Antigen,Factor VIII Procoagulant Activity,Thromboplastinogen,Blood Coagulation Factor VIII,F VIII-C,Factor 8,Factor 8 C,Factor Eight,Factor VIIIC,Hyate-C,Hyatt-C,F VIII C,Hyate C,HyateC,Hyatt C,HyattC
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

V Tichelaar, and H de Jong, and H Nijland, and H Kluin-Nelemans, and K Meijer, and A Mulder
Comparisons of one-stage and two-stage assays of Factor VIII:C.
January 1984, Scandinavian journal of haematology. Supplementum,
V Tichelaar, and H de Jong, and H Nijland, and H Kluin-Nelemans, and K Meijer, and A Mulder
Diagnostic testing for mild hemophilia a in patients with discrepant one-stage, two-stage, and chromogenic factor VIII:C assays.
April 2013, Seminars in thrombosis and hemostasis,
V Tichelaar, and H de Jong, and H Nijland, and H Kluin-Nelemans, and K Meijer, and A Mulder
Recombinant factor IX: discrepancies between one-stage clotting and chromogenic assays.
November 2014, Haemophilia : the official journal of the World Federation of Hemophilia,
V Tichelaar, and H de Jong, and H Nijland, and H Kluin-Nelemans, and K Meijer, and A Mulder
Recombinant to modified factor VIII and factor IX - chromogenic and one-stage assays issues.
July 2016, Haemophilia : the official journal of the World Federation of Hemophilia,
V Tichelaar, and H de Jong, and H Nijland, and H Kluin-Nelemans, and K Meijer, and A Mulder
On the unreliability of one-stage factor VIII:C clotting assays after infusion of factor VIII concentrates.
October 1987, Scandinavian journal of clinical and laboratory investigation,
V Tichelaar, and H de Jong, and H Nijland, and H Kluin-Nelemans, and K Meijer, and A Mulder
One-stage vs. chromogenic assays in haemophilia A.
February 2015, European journal of haematology,
V Tichelaar, and H de Jong, and H Nijland, and H Kluin-Nelemans, and K Meijer, and A Mulder
A critical appraisal of one-stage and chromogenic assays of factor VIII activity.
February 2016, Journal of thrombosis and haemostasis : JTH,
V Tichelaar, and H de Jong, and H Nijland, and H Kluin-Nelemans, and K Meijer, and A Mulder
Discrepancy between one-stage and two-stage assay of factor VIII:C.
October 1978, British journal of haematology,
V Tichelaar, and H de Jong, and H Nijland, and H Kluin-Nelemans, and K Meijer, and A Mulder
Reproducibility of one-stage, two-stage and chromogenic assays of factor VIII activity: a multi-center study.
February 1991, Thrombosis research,
V Tichelaar, and H de Jong, and H Nijland, and H Kluin-Nelemans, and K Meijer, and A Mulder
Assay of factor VIII:C with a chromogenic substrate.
January 1984, Scandinavian journal of haematology. Supplementum,
Copied contents to your clipboard!